Potrero Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 56
Employees
  • Latest Deal Type
  • Series C3
  • Latest Deal Amount
  • $42M
Latest Deal Amount
  • Investors
  • 16

Potrero General Information

Description

Developer of predictive health monitoring system designed to improve patient care using artificial intelligence and machine insights. The company's platform monitors the urine output and core body temperature, in degrees Fahrenheit and degrees Celsius and also measures intra-abdominal pressure, assisting medical teams to better predict adverse outcomes in critical care settings.

Contact Information

Website
www.potreromed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • 26142 Eden Landing Road
  • Hayward, CA 94545
  • United States
+1 (888) 000-0000

Potrero Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Potrero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C3) 21-Aug-2020 $42M 00000 00000 Completed Generating Revenue
7. Debt - PPP 14-Apr-2020 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series C2) 29-Oct-2019 000.00 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 09-Jul-2018 000.00 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 07-Aug-2017 0000 000.00 0000 Completed Generating Revenue
3. Grant 01-Jan-2017 00.000 00.00 Completed Startup
2. Early Stage VC (Series A) 23-May-2014 $3.9M $3.9M 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Potrero’s complete valuation and funding history, request access »

Potrero Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C3 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series B 8,457,337 $0.000100 $0.03 $1.12 $1.12 1x $1.12 7.61%
Series A 12,241,634 $0.000100 $0.03 $0.49 $0.49 1x $0.49 11.01%
To view Potrero’s complete cap table history, request access »

Potrero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of predictive health monitoring system designed to improve patient care using artificial intelligence and mach
Monitoring Equipment
Hayward, CA
56 As of 2020
00000
0000 0000-00-00
00000000000 00000

00000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000000000 000000000
Jerusalem, Israel
00 As of 0000
00.00
0000000000 00.00

000000 0

t labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
00000000000 0000000
Marlborough, MA
00000 As of 0000
00000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Potrero Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RenalSense Angel-Backed Jerusalem, Israel 00 00.00 0000000000 00.00
000000 0000000000 Corporation Marlborough, MA 00000 00000 000000&0
0000000 0000000 00 Corporate Backed or Acquired Raleigh, NC 000000&0
00 0000000 0000000 Formerly PE-Backed Franklin Lakes, NJ 000000000000
00000000 000000 Corporation Dublin, OH 00000 0000
You’re viewing 5 of 9 competitors. Get the full list »

Potrero Executive Team (15)

Name Title Board Seat Contact Info
Joseph Urban President, Chief Executive Officer & Board Member
Jeff Mack Chief Financial Officer
Sanjay Banerjee Chief Operating Officer
Saheel Sutaria Chief Technology Officer
Rebecca Lin Vice President of Strategy & Global Business Development
You’re viewing 5 of 15 executive team members. Get the full list »

Potrero Board Members (10)

Name Representing Role Since
Alan Chesler Self Board Member 000 0000
Andrew Offer Self Board Member 000 0000
Carter Meyer JD Scientific Health Development Board Member 000 0000
Daniel Burnett MD Self Founder & Chairman 000 0000
Frederic Moll MD Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Potrero Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Potrero Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Baxter International Corporation Minority 000 0000 000000 0
Inspire Global Ventures Venture Capital Minority 000 0000 000000 0
Green Park & Golf Ventures Venture Capital Minority 000 0000 000000 0
GT Healthcare Capital Partners Venture Capital Minority 000 0000 000000 0
Sonder Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Potrero Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 26-Aug-2019 00000 00000 00 000 Surgical Devices
To view Potrero’s complete investments history, request access »

Ready to get started?

Request a free trial